Health Economics & Outcomes Research
Exponent has a wide array of scientific, technical, and analytical experience to support increasingly complex health economics and outcomes research studies. Consultants with background and experience in healthcare, the pharmaceutical and biotech industry, as well as academia and government regulatory agencies, bring a multi-disciplinary rigor and familiarity with the challenges of demonstrating value of a health product or service.
The number and diversity of stakeholders in evaluating health economic outcomes is increasing and each perspective must be addressed. In the case of pharmaceutical and biologic agents, determination of coverage may be based on both cost-effectiveness and budget impact. For diagnostic or capital equipment, hospitals or health systems need to understand the costs and potential benefits in terms of faster and more accurate treatment or lower readmission rates and penalties. Surgeons may hold a primary decision-making role in the adoption of new implanted technologies, and their focus may be more on improving patient quality of life than purely clinical outcomes. Food suppliers and manufacturers of vaccines may have to address the public health community as they develop an economic case for functional foods or non-mandatory vaccines.
Exponent’s Expertise in Health Economics and Outcomes Research
Exponent can provide advanced HEOR guidance to develop solutions for clients in the following sectors:
- Pharmaceutical, Medical Device, and Biotechnology Industries
- Healthcare Payers (including self-insured corporations)
- Healthcare Providers
- New Technology Manufacturers (mobile, wearables, nanotechnology)
To streamline our HEOR analyses we maintain a number of Medicare, HCUP, and other government-maintained databases in-house, and can augment our in-house sets with other public and commercial/private databases as needed.